These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 29750358)
1. A population-based cost-effectiveness study of early genetic testing in severe epilepsies of infancy. Howell KB; Eggers S; Dalziel K; Riseley J; Mandelstam S; Myers CT; McMahon JM; Schneider A; Carvill GL; Mefford HC; ; Scheffer IE; Harvey AS Epilepsia; 2018 Jun; 59(6):1177-1187. PubMed ID: 29750358 [TBL] [Abstract][Full Text] [Related]
2. Recent advances in neurometabolic diseases: The genetic role in the modern era. Tein I Epilepsy Behav; 2023 Aug; 145():109338. PubMed ID: 37453291 [TBL] [Abstract][Full Text] [Related]
3. Reducing the Cost of the Diagnostic Odyssey in Early Onset Epileptic Encephalopathies. Joshi C; Kolbe DL; Mansilla MA; Mason SO; Smith RJ; Campbell CA Biomed Res Int; 2016; 2016():6421039. PubMed ID: 27243033 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic Yield and Treatment Impact of Targeted Exome Sequencing in Early-Onset Epilepsy. Demos M; Guella I; DeGuzman C; McKenzie MB; Buerki SE; Evans DM; Toyota EB; Boelman C; Huh LL; Datta A; Michoulas A; Selby K; Bjornson BH; Horvath G; Lopez-Rangel E; van Karnebeek CDM; Salvarinova R; Slade E; Eydoux P; Adam S; Van Allen MI; Nelson TN; Bolbocean C; Connolly MB; Farrer MJ Front Neurol; 2019; 10():434. PubMed ID: 31164858 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic yield of targeted massively parallel sequencing in children with epileptic encephalopathy. Kothur K; Holman K; Farnsworth E; Ho G; Lorentzos M; Troedson C; Gupta S; Webster R; Procopis PG; Menezes MP; Antony J; Ardern-Holmes S; Dale RC; Christodoulou J; Gill D; Bennetts B Seizure; 2018 Jul; 59():132-140. PubMed ID: 29852413 [TBL] [Abstract][Full Text] [Related]
6. Epilepsy syndromes, etiologies, and the use of next-generation sequencing in epilepsy presenting in the first 2 years of life: A population-based study. Stödberg T; Tomson T; Barbaro M; Stranneheim H; Anderlid BM; Carlsson S; Åmark P; Wedell A Epilepsia; 2020 Nov; 61(11):2486-2499. PubMed ID: 32964447 [TBL] [Abstract][Full Text] [Related]
7. Genetic diagnoses in epilepsy: The impact of dynamic exome analysis in a pediatric cohort. Rochtus A; Olson HE; Smith L; Keith LG; El Achkar C; Taylor A; Mahida S; Park M; Kelly M; Shain C; Rockowitz S; Rosen Sheidley B; Poduri A Epilepsia; 2020 Feb; 61(2):249-258. PubMed ID: 31957018 [TBL] [Abstract][Full Text] [Related]
9. Clinical and Electroencephalographic Characteristics of Infantile-Onset Epilepsies Caused by Genetic Mutations. Hur YJ; Koh S; Millichap J; Nangia S; Jennings LJ; Nordli DR J Pediatr; 2017 May; 184():172-177.e1. PubMed ID: 28410084 [TBL] [Abstract][Full Text] [Related]
10. Whole exome sequencing in neurogenetic odysseys: An effective, cost- and time-saving diagnostic approach. Córdoba M; Rodriguez-Quiroga SA; Vega PA; Salinas V; Perez-Maturo J; Amartino H; Vásquez-Dusefante C; Medina N; González-Morón D; Kauffman MA PLoS One; 2018; 13(2):e0191228. PubMed ID: 29389947 [TBL] [Abstract][Full Text] [Related]
11. A scoping study to explore the cost-effectiveness of next-generation sequencing compared with traditional genetic testing for the diagnosis of learning disabilities in children. Beale S; Sanderson D; Sanniti A; Dundar Y; Boland A Health Technol Assess; 2015 Jun; 19(46):1-90. PubMed ID: 26132578 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic Impact and Cost-effectiveness of Whole-Exome Sequencing for Ambulant Children With Suspected Monogenic Conditions. Tan TY; Dillon OJ; Stark Z; Schofield D; Alam K; Shrestha R; Chong B; Phelan D; Brett GR; Creed E; Jarmolowicz A; Yap P; Walsh M; Downie L; Amor DJ; Savarirayan R; McGillivray G; Yeung A; Peters H; Robertson SJ; Robinson AJ; Macciocca I; Sadedin S; Bell K; Oshlack A; Georgeson P; Thorne N; Gaff C; White SM JAMA Pediatr; 2017 Sep; 171(9):855-862. PubMed ID: 28759686 [TBL] [Abstract][Full Text] [Related]
13. Incidence and phenotypes of childhood-onset genetic epilepsies: a prospective population-based national cohort. Symonds JD; Zuberi SM; Stewart K; McLellan A; O'Regan M; MacLeod S; Jollands A; Joss S; Kirkpatrick M; Brunklaus A; Pilz DT; Shetty J; Dorris L; Abu-Arafeh I; Andrew J; Brink P; Callaghan M; Cruden J; Diver LA; Findlay C; Gardiner S; Grattan R; Lang B; MacDonnell J; McKnight J; Morrison CA; Nairn L; Slean MM; Stephen E; Webb A; Vincent A; Wilson M Brain; 2019 Aug; 142(8):2303-2318. PubMed ID: 31302675 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic Yield and Economic Implications of Whole-Exome Sequencing for ASD Diagnosis in Israel. Tal-Ben Ishay R; Shil A; Solomon S; Sadigurschi N; Abu-Kaf H; Meiri G; Flusser H; Michaelovski A; Dinstein I; Golan H; Davidovitch N; Menashe I Genes (Basel); 2021 Dec; 13(1):. PubMed ID: 35052376 [TBL] [Abstract][Full Text] [Related]
15. Epidemiology and etiology of infantile developmental and epileptic encephalopathies in Tasmania. Ware TL; Huskins SR; Grinton BE; Liu YC; Bennett MF; Harvey M; McMahon J; Andreopoulos-Malikotsinas D; Bahlo M; Howell KB; Hildebrand MS; Damiano JA; Rosenfeld A; Mackay MT; Mandelstam S; Leventer RJ; Harvey AS; Freeman JL; Scheffer IE; Jones DL; Berkovic SF Epilepsia Open; 2019 Sep; 4(3):504-510. PubMed ID: 31440733 [TBL] [Abstract][Full Text] [Related]
16. Early-Life Epilepsies and the Emerging Role of Genetic Testing. Berg AT; Coryell J; Saneto RP; Grinspan ZM; Alexander JJ; Kekis M; Sullivan JE; Wirrell EC; Shellhaas RA; Mytinger JR; Gaillard WD; Kossoff EH; Valencia I; Knupp KG; Wusthoff C; Keator C; Dobyns WB; Ryan N; Loddenkemper T; Chu CJ; Novotny EJ; Koh S JAMA Pediatr; 2017 Sep; 171(9):863-871. PubMed ID: 28759667 [TBL] [Abstract][Full Text] [Related]
17. Incidence and outcome of epilepsy syndromes with onset in the first year of life: A retrospective population-based study. Gaily E; Lommi M; Lapatto R; Lehesjoki AE Epilepsia; 2016 Oct; 57(10):1594-1601. PubMed ID: 27574005 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of the feasibility, diagnostic yield, and clinical utility of rapid genome sequencing in infantile epilepsy (Gene-STEPS): an international, multicentre, pilot cohort study. D'Gama AM; Mulhern S; Sheidley BR; Boodhoo F; Buts S; Chandler NJ; Cobb J; Curtis M; Higginbotham EJ; Holland J; Khan T; Koh J; Liang NSY; McRae L; Nesbitt SE; Oby BT; Paternoster B; Patton A; Rose G; Scotchman E; Valentine R; Wiltrout KN; ; ; Hayeems RZ; Jain P; Lunke S; Marshall CR; Rockowitz S; Sebire NJ; Stark Z; White SM; Chitty LS; Cross JH; Scheffer IE; Chau V; Costain G; Poduri A; Howell KB; McTague A Lancet Neurol; 2023 Sep; 22(9):812-825. PubMed ID: 37596007 [TBL] [Abstract][Full Text] [Related]
19. Early childhood epilepsies: epidemiology, classification, aetiology, and socio-economic determinants. Symonds JD; Elliott KS; Shetty J; Armstrong M; Brunklaus A; Cutcutache I; Diver LA; Dorris L; Gardiner S; Jollands A; Joss S; Kirkpatrick M; McLellan A; MacLeod S; O'Regan M; Page M; Pilley E; Pilz DT; Stephen E; Stewart K; Ashrafian H; Knight JC; Zuberi SM Brain; 2021 Oct; 144(9):2879-2891. PubMed ID: 34687210 [TBL] [Abstract][Full Text] [Related]
20. Does genomic sequencing early in the diagnostic trajectory make a difference? A follow-up study of clinical outcomes and cost-effectiveness. Stark Z; Schofield D; Martyn M; Rynehart L; Shrestha R; Alam K; Lunke S; Tan TY; Gaff CL; White SM Genet Med; 2019 Jan; 21(1):173-180. PubMed ID: 29765138 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]